Key Update

The Karnataka High Court has stayed an advisory issued by the Food Safety and Standards Authority of India (FSSAI) that prohibited the use of Ashwagandha leaves or leaf extracts in supplements over safety concerns flagged by the Union Ministry of Ayush. Justice S R Krishna Kumar passed the interim order on Tuesday, staying the advisory dated April 16 in relation to petitioners Sami-Sabinsa Group Ltd and Kerry Inc until the next hearing. The companies had approached the court seeking to quash the advisory.

Safety Concerns Over Ashwagandha Leaves

Ashwagandha is widely sold as an adaptogenic supplement that supports strength and sexual wellness, particularly among men. Authorities raised concerns that Ashwagandha leaves contain higher levels of reactive withanolides, especially withaferin-A, which may cause liver toxicity, gastrointestinal distress, and possible neurotoxic effects.

In its April directive, the Ministry of Ayush advised manufacturers, exporters, and sellers of Ayush products not to use Ashwagandha leaves in crude, extract, or any other form.

Companies Challenge Advisory

Senior Advocate K G Raghavan, appearing for the petitioners, argued that the companies manufacture products using Ashwagandha roots, leaves, and extracts in line with the Food Safety and Standards Regulations, 2016, framed under the Food Safety and Standards Act, 2006. He contended that authorities cannot prohibit the use of certain plant parts through a simple advisory without formally amending the 2016 regulations. Raghavan also pointed out that the companies have used Ashwagandha leaves in their products for more than 30 years. The petitioners further argued that restricting its use would severely affect their business operations.

Matter Posted for Further Hearing

Counsel representing the Union Government and FSSAI sought time to file objections to the petitions. Following this, the court granted interim relief and posted the matter for further hearing on June 8.

Source: The Indian Express